Serum proteomic profiling in patients with bladder cancer

Area of Science:

• Biochemistry
• Proteomics
• Oncology

Background:

• Accurate bladder cancer biomarkers are lacking, hindering sensitive and specific detection.
• Current diagnostic methods face challenges with sensitivity and specificity.

Purpose of the Study:

• To identify discriminating serum protein patterns for bladder cancer detection.
• To evaluate the efficacy of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in identifying bladder cancer patients.

Main Methods:

• Serum samples from 105 bladder cancer patients, 98 healthy controls, and 45 prostate cancer patients were analyzed.
• Magnetic bead-based separation followed by MALDI-TOF MS was employed for serum fractionation and analysis.
• Multidimensional data analysis generated algorithms for distinguishing cancer patients from controls, validated on independent datasets.

Main Results:

• The training set achieved 94.1% sensitivity and 89.2% specificity for bladder cancer identification.
• The independent test set demonstrated high performance with 96.4% sensitivity and 86.5% specificity.
• Low-stage bladder tumors were predicted with 96% sensitivity, and distinguished from higher-stage tumors with 77.3% sensitivity.

Conclusions:

• Serum protein pattern screening using MALDI-TOF MS offers high sensitivity and specificity for bladder cancer detection.
• The identified differential protein panel, with its high-throughput capability, shows potential for improving bladder cancer detection rates.
• This method holds promise for non-invasive bladder cancer screening and diagnosis, regardless of tumor stage.